InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Liu Ye. Director active across 1 company, notably EyePoint Pharmaceuticals, Inc.. Cumulatively, 3 disclosures have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €47.3m. Activity tracked since 30 May 2023. The latest transaction was filed on 11 January 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
3 of 3 declarations